Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (42)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Aouifi, A.
Right arrow Articles by Lehot, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aouifi, A.
Right arrow Articles by Lehot, J. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, Vol 83, Issue 4 602-607, Copyright © 1999 by The Board of Management and Trustees of the British Journal of Anaesthesia


CLINICAL INVESTIGATIONS

Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations

A. Aouifi, V. Piriou, P. Blanc, H. Bouvier, O. Bastien, P. Chiari, R. Rousson, R. Evans and J. J. Lehot
Service d'Anesthesie-Reanimation and EA 1896, Universite Claude Bernard, Lyon I, France; Laboratoire de Biochime, Hopital Cardiovasculaire et Pneumologique L. Pradel, Lyon, France; Nuffield Department of Anaesthetics, Radcliffe Infirmary, Oxford OX2 6HE, UK

We have measured serum procalcitonin (PCT) concentrations after cardiac surgery in 36 patients allocated to one of three groups: group 1, coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB) (n = 12); group 2, CABG without CPB (n = 12); and group 3, valvular surgery with CPB (n = 12). Serum PCT and C-reactive protein (CRP) concentrations were measured before operation, at the end of surgery and daily until postoperative day 8. Serum PCT concentrations increased, irrespective of the type of cardiac surgery, with maximum concentrations on day 1: mean 1.3 (SD 1.8), 1.1 (1.2) and 1.4 (1.2) ng ml-1 in groups 1, 2 and 3, respectively (ns). Serum PCT concentrations remained less than 5 ng ml-1 in all patients. Concentrations returned to normal by day 5 in all groups. To determine the effect of the systemic inflammatory response (SIRS) on serum PCT concentrations, patients were divided post hoc, without considering the type of cardiac surgery, into patients with SIRS (n = 19) and those without SIRS (n = 17). The increase in serum PCT was significantly greater in SIRS (peak PCT 1.79 (1.64) ng ml-1 vs 0.34 (0.32) ng ml-1 in patients without SIRS) (P = 0.005). Samples for PCT and CRP measurements were obtained from 10 other patients with postoperative complications (circulatory failure n = 7; active endocarditis n = 2; septic shock n = 1). In these patients, serum PCT concentrations ranged from 6.2 to 230 ng ml-1. Serum CRP concentrations increased in all patients, with no differences between groups. The postoperative increase in CRP lasted longer than that of PCT. We conclude that SIRS induced by cardiac surgery, with and without CPB, influenced serum PCT concentrations with a moderate and transient postoperative peak on the first day after operation. A postoperative serum PCT concentration of more than 5 ng ml-1 is highly suggestive of a postoperative complication.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur Heart JHome page
D. Kaireviciute, A. Aidietis, and G. Y.H. Lip
Atrial fibrillation following cardiac surgery: clinical features and preventative strategies
Eur. Heart J., February 2, 2009; 30(4): 410 - 425.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Vollmer, C. Piper, K. Kleesiek, and J. Dreier
Lipopolysaccharide-Binding Protein: A New Biomarker for Infectious Endocarditis?
Clin. Chem., February 1, 2009; 55(2): 295 - 304.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
E. E. Apostolakis, C. Prokakis, and D. Dougenis
Are procalcitonin levels sufficient for the follow up of patients undergoing lung decortication for pleural empyema?
Eur. J. Cardiothorac. Surg., January 1, 2009; 35(1): 193 - 193.
[Full Text] [PDF]


Home page
CirculationHome page
M. Pretorius, B. S. Donahue, C. Yu, J. P. Greelish, D. M. Roden, and N. J. Brown
Plasminogen Activator Inhibitor-1 as a Predictor of Postoperative Atrial Fibrillation After Cardiopulmonary Bypass
Circulation, September 11, 2007; 116(11_suppl): I-1 - I-7.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. Sander, C. von Heymann, V. v. Dossow, C. Spaethe, W. F. Konertz, U. Jain, and C. D. Spies
Increased interleukin-6 after cardiac surgery predicts infection.
Anesth. Analg., June 1, 2006; 102(6): 1623 - 1629.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
L. Visser, C. J. Zuurbier, F. J. Hoek, B. C. Opmeer, E. de Jonge, B. A. J. M. de Mol, and H. B. van Wezel
Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery
Br. J. Anaesth., October 1, 2005; 95(4): 448 - 457.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
F. Macrina, L. Tritapepe, F. Pompei, A. Sciangula, E. Evangelista, F. Toscano, A. Criniti, G. Brancaccio, and P. E. Puddu
Procalcitonin is useful whereas C-reactive protein is not, to predict complications following coronary artery bypass surgery
Perfusion, May 1, 2005; 20(3): 169 - 175.
[Abstract] [PDF]


Home page
Br J AnaesthHome page
F. Kerbaul, R. Giorgi, C. Oddoze, F. Collart, C. Guidon, P. J. Lejeune, J. Villacorta, and F. Gouin
High concentrations of N-BNP are related to non-infectious severe SIRS associated with cardiovascular dysfunction occurring after off-pump coronary artery surgery
Br. J. Anaesth., November 1, 2004; 93(5): 639 - 644.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Papafili, M. R. Hill, D. J. Brull, R. J. McAnulty, R. P. Marshall, S. E. Humphries, and G. J. Laurent
Common Promoter Variant in Cyclooxygenase-2 Represses Gene Expression: Evidence of Role in Acute-Phase Inflammatory Response
Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1631 - 1636.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.